Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging

Area of Science:

• Nuclear Medicine
• Oncology
• Radiopharmaceuticals

Background:

• Prostate cancer diagnosis and staging rely on accurate detection of nodal metastasis.
• Current imaging methods for nodal metastasis can be time-consuming and uncomfortable for patients.
• Precise localization of metastatic lymph nodes is crucial for treatment planning.

Purpose of the Study:

• To describe and evaluate a novel dual-isotope imaging protocol for detecting and localizing nodal metastasis in prostate cancer.
• To compare the efficiency and accuracy of the dual-isotope method against the standard single-isotope technique.

Main Methods:

• A dual-isotope imaging protocol was developed using Technetium-99m (99mTc)-labeled red blood cells and Indium-111 (111In) capromab pendetide.
• The protocol utilizes a single SPECT (Single-Photon Emission Computed Tomography) acquisition.
• Forty patients with prostate cancer were studied using this protocol.

Main Results:

• The dual-isotope protocol demonstrated preliminary increased accuracy in detecting nodal metastasis compared to the single-isotope technique.
• The single SPECT acquisition is less time-consuming and more patient-friendly than methods requiring multiple acquisitions on different days.

Conclusions:

• The dual-isotope technique provides precise image registration, enabling accurate comparison of blood pool and pelvic lymph node activity.
• This improved image registration facilitates confident and accurate interpretation for staging prostate cancer.
• The protocol offers a more efficient and accurate approach to imaging nodal metastasis.